| Title: |
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021 |
| Authors: |
Thomson, AM; McHugh, TA; Oron, AP; Teply, C; Lonberg, N; Vilchis Tella, V; Wilner, LB; Fuller, K; Hagins, H; Aboagye, RG; Aboye, MB; Abu-Gharbieh, E; Abu-Zaid, A; Addo, IY; Ahinkorah, BO; Ahmad, A; AlRyalat, SAS; Amu, H; Aravkin, AY; Arulappan, J; Atout, MMW; Badiye, AD; Bagherieh, S; Banach, M; Banakar, M; Bardhan, M; Barrow, A; Bedane, DA; Bensenor, IM; Bhagavathula, AS; Bhardwaj, P; Bhardwaj, PV; Bhat, AN; Bhutta, ZA; Bilalaga, MM; Bishai, JD; Bitaraf, S; Boloor, A; Butt, MH; Chattu, VK; Chu, D-T; Dadras, O; Dai, X; Danaei, B; Dang, AK; Demisse, FW; Dhimal, M; Diaz, D; Djalalinia, S; Dongarwar, D; Elhadi, M; Elmonem, MA; Esezobor, CI; Etaee, F; Eyawo, O; Fagbamigbe, AF; Fatehizadeh, A; Force, LM; Gardner, WM; Ghaffari, K; Gill, PS; Golechha, M; Goleij, P; Gupta, VK; Hasani, H; Hassan, TS; Hassen, MB; Ibitoye, SE; Ikiroma, AI; Iwu, CCD; James, PB; Jayaram, S; Jebai, R; Jha, RP; Joseph, N; Kalantar, F; Kandel, H; Karaye, IM; Kassahun, WD; Khan, IA; Khanmohammadi, S; Kisa, A; Kompani, F; Krishan, K; Landires, I; Lim, SS; Mahajan, PB; Mahjoub, S; Majeed, A; Marasini, BP; Meresa, HA; Mestrovic, T; Minhas, S; Misganaw, A; Mokdad, AH; Monasta, L; Mustafa, G; Nair, TS; Narasimha Swamy, S; Nassereldine, H; Natto, ZS; Naveed, M; Nayak, BP; Noubiap, JJ; Noyes, T; Nri-ezedi, CA; Nwatah, VE; Nzoputam, CI; Nzoputam, OJ; Okonji, OC; Onikan, AO; Owolabi, MO; Patel, J; Pati, S; Pawar, S; Petcu, I-R; Piel, FB; Qattea, I; Rahimi, M; Rahman, M; Rawaf, S; Redwan, EMM; Rezaei, N; Saddik, B; Saeed, U; Saheb Sharif-Askari, F; Samy, AM; Schumacher, AE; Shaker, E; Shetty, A; Sibhat, MM; Singh, JA; Suleman, M; Sunuwar, DR; Szeto, MD; Tamuzi, JJLL; Tat, NY; Taye, BT; Temsah, M-H; Umair, M; Valadan Tahbaz, S; Wang, C; Wickramasinghe, ND; Yigit, A; Yiğit, V; Yunusa, I; Zaman, BA; Zangiabadian, M; Zheng, P; Hay, SI; Naghavi, M; Murray, CJL; Kassebaum, NJ |
| Source: |
e599 ; e585 |
| Publisher Information: |
Elsevier |
| Publication Year: |
2023 |
| Collection: |
Imperial College London: Spiral |
| Subject Geographic: |
England |
| Description: |
BACKGROUND: Previous global analyses, with known underdiagnosis and single cause per death attribution systems, provide only a small insight into the suspected high population health effect of sickle cell disease. Completed as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, this study delivers a comprehensive global assessment of prevalence of sickle cell disease and mortality burden by age and sex for 204 countries and territories from 2000 to 2021. METHODS: We estimated cause-specific sickle cell disease mortality using standardised GBD approaches, in which each death is assigned to a single underlying cause, to estimate mortality rates from the International Classification of Diseases (ICD)-coded vital registration, surveillance, and verbal autopsy data. In parallel, our goal was to estimate a more accurate account of sickle cell disease health burden using four types of epidemiological data on sickle cell disease: birth incidence, age-specific prevalence, with-condition mortality (total deaths), and excess mortality (excess deaths). Systematic reviews, supplemented with ICD-coded hospital discharge and insurance claims data, informed this modelling approach. We employed DisMod-MR 2.1 to triangulate between these measures-borrowing strength from predictive covariates and across age, time, and geography-and generated internally consistent estimates of incidence, prevalence, and mortality for three distinct genotypes of sickle cell disease: homozygous sickle cell disease and severe sickle cell β-thalassaemia, sickle-haemoglobin C disease, and mild sickle cell β-thalassaemia. Summing the three models yielded final estimates of incidence at birth, prevalence by age and sex, and total sickle cell disease mortality, the latter of which was compared directly against cause-specific mortality estimates to evaluate differences in mortality burden assessment and implications for the Sustainable Development Goals (SDGs). FINDINGS: Between 2000 and 2021, national incidence rates of ... |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
The Lancet Haematology; http://hdl.handle.net/10044/1/105935 |
| DOI: |
10.1016/S2352-3026(23)00118-7 |
| Availability: |
http://hdl.handle.net/10044/1/105935; https://doi.org/10.1016/S2352-3026(23)00118-7 |
| Rights: |
© 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ; https://creativecommons.org/licenses/by/4.0/ |
| Accession Number: |
edsbas.E5B0243A |
| Database: |
BASE |